Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 39, Issue 5, 1996, Pages 792-796

  Tsuchiya, Naoyuki ^a,b   Shiota, Michiko ^a   Yamaguchi, Akihiro ^a   Ito, Koji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; BIOCHEMICAL MARKER; HLA ANTIGEN CLASS 1;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG BLOOD LEVEL; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ARTHRITIS, RHEUMATOID; BETA 2-MICROGLOBULIN; CENTRAL NERVOUS SYSTEM DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; REFERENCE VALUES; SOLUBILITY;

EID: 0029876250     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390511     Document Type: Article

References (16)

1. Westlioff U, Doxiadis I, Beelen DW, Schaefer UW, Grosse-Wilde H: Soluble HLA class I concentrations and GVHD after allogeneic marrow transplantation. Transplantation 48:891-893, 1989
2. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ: Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum Immunol 40:191-201, 1994
3. Puppo F, Brenci S, Lanza L, Bosco O, Imro MA, Scudeletti M, Indiveri F, Ferrone S: Increased level of serum HLA class I antigens in HIV infection: correlation with disease progression. Hum Immunol 40:259-266, 1994
4. Sakaguchi K, Koide N, Takenami T, Matsushima H, Takabatake H, Ferrone S, Tsuji T: Soluble HLA class I antigens in sera of patients with chronic hepatitis. Gastroenterol Jpn 27: 206-211, 1992
5. Puppo F, Scudeletti M, Indiveru F, Ferrone S: Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 16:124-127, 1995
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
7. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630-640, 1992
8. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
9. Puppo F, Pellicci R, Brenci S, Nocera A, Morelli N, Dardano G, Bertocchi M, Antonucci A, Ohio M, Scudeletti M, Baroci S, Valente U, Indiveri F: HLA class-I-soluble antigen serum levels in liver transplantation: a predictor marker of acute rejection. Hum Immunol 40:166-170, 1994
10. Pouletty P, Ferrone S, Amesland F, Cohen N, Westhoff U, Charron D, Shimizu RM, Grosse-Wilde H: Summary report from the first international workshop on soluble HLA antigens, Paris, August 1992. Tissue Antigens 42:45-54, 1993
11. Hagihara M, Shimura T, Yamamoto K, Sujirachato K, Tsuji S, Yamamura M, Tsuji K: Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus. Tokai J Exp Clin Med 18:61-64, 1993
12. Kao KJ, Scomik JC, Riley WJ, McQueen CF: Association between HLA phenotype and HLA concentration in plasma or platelets. Hum Immunol 21:115-124, 1988
13. Hashimoto H, Tsuda H, Matsumoto T, Nasu H, Takasaki Y, Shiokawa Y, Hirose S, Terasaki PI, Iwaki Y: HLA antigens associated with systemic lupus erythematosus in Japan. J Rheumatol 12:919-923, 1985
14. Tsuchiya N, Mitamura T, Goto M, Moroi Y, Kinoshita M, Yokohari R, Miyamoto T: 2-dimensional flow cytometric analysis of peripheral blood T lymphocytes from patients with systemic lupus erythematosus: preferential expression of HLA-DR antigen on the surface of Leu 2a+ cells. J Rheumatol 15:946-951, 1988
15. Aulitzky WE, Grosse-Wilde H, Westhoff U, Tilg H, Aulitzky W, Gastl G, Herold M, Huber C: Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-γ). Clin Exp Immunol 86:236-239, 1991
16. Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T: Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 70:562-569, 1987